Login to Your Account

Financings Roundup

Monday, February 4, 2013
• Stemline Therapeutics Inc., of New York, closed its initial public offering of 3.8 million shares, including the exercise in full of the overallotment option covering 497,647 shares, at a price of $10 per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription